Goldman Sachs Group Inc Amphastar Pharmaceuticals, Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 449,389 shares of AMPH stock, worth $19.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
449,389
Previous 153,606
192.56%
Holding current value
$19.8 Million
Previous $6.14 Million
254.95%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding AMPH
# of Institutions
287Shares Held
35.1MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$262 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$120 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$94.1 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$85.8 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$71.2 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.16B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...